Tybriva 140 Mg Capsules

Tybriva 140 mg Capsules contains ibrutinib, a Bruton’s tyrosine kinase (BTK) inhibitor, used to treat various blood cancers.

Uses:

• Mantle Cell Lymphoma (MCL): A rare, aggressive form of non-Hodgkin’s lymphoma.
• Chronic Lymphocytic Leukemia (CLL): A slow-growing cancer of the bone marrow and blood.
• Small Lymphocytic Lymphoma (SLL): Similar to CLL but primarily affects lymph nodes.
• Waldenström’s Macroglobulinemia: A rare type of non-Hodgkin lymphoma characterized by excess production of abnormal white blood cells.
• Marginal Zone Lymphoma (MZL): A group of slow-growing B-cell lymphomas.
• Chronic Graft Versus Host Disease (cGvHD): A complication following allogeneic stem cell transplantation.

Dosage and Administration:

Take Tybriva 140 mg Capsule orally at the same time each day, with or without food, as directed by your physician. Swallow the capsule whole; do not crush, chew, or open it. Avoid consuming grapefruit or oranges in any form during treatment, as they may increase drug levels in the blood. Maintain adequate hydration by drinking plenty of fluids.

Common Side Effects:

• Fever
• Headache
• Fatigue
• Musculoskeletal pain
• Rash
• Anemia
• Bruising
• Muscle spasms
• Hemorrhage
• Pneumonia
• Cough
• Diarrhea
• Stomatitis (inflammation of the mouth)
• Nausea
• Low blood platelets
• Decreased white blood cell count (neutrophils)
• Dry eye
• High blood pressure
• Weight loss
• Urinary tract infection
• Peripheral edema
• Subdural hematoma
• Second primary malignancies

Safety Advice:

• Alcohol: Consult your doctor regarding alcohol consumption during treatment.
• Pregnancy: Not recommended due to potential risks to the developing baby.
• Breastfeeding: Use with caution; breastfeeding should be paused until the drug is eliminated from the body.
• Driving: May cause side effects that could impair driving ability.
• Kidney and Liver Health: Patients with kidney or liver disease should use Tybriva cautiously, with possible dose adjustments.

Available Substitutes:

• Imbruvica 140 mg Capsule by Janssen Pharmaceuticals
• Nitib 140 mg Capsule by Hetero Healthcare Limited
• Ibrukem Capsule by Alkem Laboratories Ltd
• Ibrushil 140 mg Capsule by Shilpa Medicare Ltd

Consult your healthcare provider before making any changes to your medication regimen.

Quick Tips:

• Take it at the same time every day, either with or without food.
• Stay hydrated during treatment.
• Do not skip any dose and complete the course as suggested by your doctor.
• Use effective birth control to avoid pregnancy while taking this medication.
• Your doctor may get regular blood tests done to monitor your liver function and blood cell count.

Conclusion:

Tybriva 140 mg Capsule is a targeted therapy for certain types of blood cancers, offering a mechanism to inhibit cancer cell growth. Patients should adhere strictly to their healthcare provider’s instructions and report any side effects or concerns promptly to ensure optimal treatment outcomes.